The relationship between depression, anxiety and cardiovascular disease: findings from the Hertfordshire Cohort Study

Richard I G Holt1, David I W Phillips, Karen A Jameson

  • 1Human Development and Health Academic Unit, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, UK. R.I.G.Holt@soton.ac.uk

Insights

Depressive and anxiety symptoms are linked to cardiovascular disease (CVD). In men, depressive symptoms independently predict CVD, mortality, and cardiovascular mortality, highlighting the importance of mental health in cardiovascular outcomes.

Area of Science:

  • Cardiology
  • Psychiatry
  • Epidemiology

Background:

  • Previous research indicates a connection between depression, anxiety, and cardiovascular disease (CVD).
  • This study investigates the relationship between depressive and anxiety symptoms and CVD in a population-based cohort.

Purpose of the Study:

  • To determine the association between depressive symptoms (using the HAD-D scale) and anxiety symptoms (using the HAD-A scale) and cardiovascular disease (CVD).
  • To assess whether these symptoms are independent predictors of CVD events and mortality.

Main Methods:

  • The Hertfordshire Cohort Study included 1578 men and 1417 women.
  • Cardiovascular disease (CVD) was assessed at baseline and after approximately 6 years.
  • Depressive and anxiety symptoms were measured using the Hospital Anxiety and Depression Scale (HADS).

Main Results:

  • Higher baseline depressive symptom scores (HAD-D) were associated with increased odds of CVD in both men and women, and with specific cardiovascular risk factors.
  • Anxiety symptoms (HAD-A) were associated with increased CVD in men only.
  • High depressive symptom scores predicted incident CVD, all-cause mortality, and cardiovascular mortality in men, but not in women.

Conclusions:

  • Depressive and anxiety symptoms are more prevalent in individuals with CVD.
  • These symptoms, particularly depression, are independent predictors of CVD in men.
  • While depressive symptoms correlate with cardiovascular risk factors, they do not fully account for the observed association with CVD.
Abstract

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Stress and Mental Health01:30

Stress and Mental Health

Chronic stress profoundly affects mental health, significantly influencing mood, behavior, and overall quality of life. Research closely links chronic stress with mental health conditions such as depression, anxiety, and substance use disorders. Ongoing exposure to stress can lead to physiological and psychological changes, initiating a cycle of emotional distress and maladaptive coping mechanisms.
Individuals with depression often experience challenges in both their personal and professional...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...